[Heart rate control in chronic heart failure patients received cardiovascular implantable electronic device therapy: effects of optimized medication].

Gao, Y; Liang, Y C; Yu, H B; Yan, X L; Xu, B G; Liu, R; Wang, N; Xu, G Q; Wang, Z L

Gao, Y; Liang, Y C; Yu, H B; Yan, X L; Xu, B G; Liu, R; Wang, N; Xu, G Q; Wang, Z L.

Affiliation

Gao Y; Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang 110016, China.

Zhonghua Xin Xue Guan Bing Za Zhi ; 46(3): 173-177, 2018 Mar 24.

Article in Zh | MEDLINE | ID: mdl-29562420

Subject(s)

Heart Failure; Heart Rate; Pacemaker, Artificial; Adrenergic beta-Antagonists/therapeutic use; Chronic Disease; Heart Failure/therapy; Humans; Ivabradine/therapeutic use

Key words

Adrenergic beta-antagonists; Cardiovascular implantable electronic device; Heart failure; Heart rate; Ivabradine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pacemaker, Artificial / Heart Failure / Heart Rate Type of study: Guideline Limits: Humans Language: Zh Journal: Zhonghua Xin Xue Guan Bing Za Zhi Year: 2018 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google